Kliniska studier för Gliom i New York
28 studier för Gliom söker deltagare vid platser i New York.
Städer i New York
- New York City25 studier
- Queens7 studier
- New Rochelle5 studier
- Greenburgh4 studier
- Staten Island4 studier
Officiell studietext (engelska)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Albany Medical Center, Albany
- Roswell Park Cancer Institute, Buffalo
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- och 4 fler
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 1 okt. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
- Columbia University Irving Medical Center, New York
- Montefiore Medical Center, The Bronx
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07326566A Study of Mirdametinib in People With Central Nervous System Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07539441Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 31 aug. 2026 · NCT05489783SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- och 2 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- New York University, New York
RekryterarFas 1
Ålder 1 till 25 · Alla kön · Uppdaterad 18 aug. 2026 · NCT04485559Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, New York
- Research Site, New York
RekryterarFas 1/2
Ålder 18 till 130 · Alla kön · Uppdaterad 12 aug. 2026 · NCT05417594Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- New York Presbyterian Hospital-Columbia University Medical Center, New York
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT07486713A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- NYU Langone Health, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT07464925A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 2
Ålder 8 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 juli 2026 · NCT05188508Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- NYU Langone Health, New York
Rekryterar
Ålder 18 till 85 · Alla kön · Uppdaterad 21 juli 2026 · NCT06910306MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 1/2
Ålder 1 till 26 · Alla kön · Uppdaterad 10 juli 2026 · NCT06712875Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 juni 2026 · NCT06666712A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 4 juni 2026 · NCT07223034Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT05954858Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT05271240Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
- Lenox Hill Brain Tumor Center, New York
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT05979064A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Roswell Park, Buffalo
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT06326411Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
- Memorial Sloan Kettering, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 apr. 2026 · NCT06126744Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 apr. 2026 · NCT06810544Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Lenox Hill Brain Tumor Center, New York
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 apr. 2026 · NCT02800486DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- Northwell Health, Lake Success
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 mars 2026 · NCT06504381FUS Etoposide for DMG
- Columbia University Irving Medical Center, New York
RekryterarFas 1
Ålder 4 till 21 · Alla kön · Uppdaterad 28 jan. 2026 · NCT05762419Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
- NYU Langone Health, New York
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 jan. 2026 · NCT06829173Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
- University of Rochester, Rochester
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 18 dec. 2025 · NCT04543201Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 10 okt. 2025 · NCT00870129Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- Northshore University Hospital, Manhasset
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 26 mars 2025 · NCT01906385Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.